ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $958,881 | -33.0% | 286,233 | -3.9% | 0.00% | – |
| Q4 2022 | $1,432,129 | +10.4% | 297,740 | +30.6% | 0.00% | – |
| Q3 2022 | $1,297,000 | +107.2% | 227,965 | +158.4% | 0.00% | – |
| Q2 2022 | $626,000 | -1.7% | 88,211 | -0.1% | 0.00% | – |
| Q1 2022 | $637,000 | +0.3% | 88,341 | +24.2% | 0.00% | – |
| Q4 2021 | $635,000 | -11.2% | 71,106 | +248.7% | 0.00% | – |
| Q3 2021 | $715,000 | -93.2% | 20,390 | -95.8% | 0.00% | -100.0% |
| Q2 2021 | $10,511,000 | +301.6% | 489,345 | +1055.0% | 0.00% | – |
| Q1 2021 | $2,617,000 | +46.7% | 42,366 | -0.8% | 0.00% | – |
| Q4 2020 | $1,784,000 | – | 42,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |